Why the study?
Does intravenous propranolol suppress recurrent paroxysmal ventricular fibrillation?
Does intravenous propranolol suppress recurrent paroxysmal ventricular fibrillation?
Intravenous propranolol successfully terminated recurrent, life-threatening paroxysmal ventricular fibrillation refractory to procainamide in a young patient.
Answers are grounded in this paper and cite their sources.
May support IV propranolol in procainamide-refractory VF; hypothesis-generating and requires prospective validation.
Beta-adrenergic receptor blocking agents such as pronethalol and pro-pranolol have been reported to be useful in the treatment of various types of arrhythmia, including ventricular flutter and fibrillation. Recently, we experienced a patient who had been suffering from recurrent attacks of paroxysmal ventricular fibrillation, which was successfully controlled by pro-pranolol (Inderal®). The patient was a 22-year-old man who was admitted with a chief complaint of recurrent episodes of retrosternal distress, occasionally associated with syncope. On examination this attack was found to be due to ventricular fibrillation. Propranolol (Inderal®) in 4mg given intravenously completely suppressed the recurrent attacks after other drugs had failed. The nature of this ventricular fibrillation was difficult to point out, but a certain localized myocarditis was suspected as a focus of abnormal myocardial irritability.
No takes yet. Share an insight, caveat, or question.
Iwatsuki et al. (1966) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: